Natera, Inc. (NTRA): Total Assets
$2.40B
As of 2025-12-31
$2.66B
As of 2026-06-30
+19.8%
3-year compound annual growth
+20.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.40B | +44.4% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $1.66B | +15.2% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $1.44B | +3.4% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $1.39B | +12.8% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $1.24B | +32.6% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $932.15M | +60.0% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $582.66M | +117.3% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $268.17M | +25.0% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $214.61M | n/c | 2019-03-15, Balance as of period end |
| 2016-12-31 | $210.68M | -20.6% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $265.24M | +114.6% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $123.62M | n/a | 2016-03-24, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Natera, Inc. (NTRA) | 2025-12-31 | $2.40B | +44.4% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $3.76B | +14.4% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.72B | -24.1% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $16.23B | +0.4% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $18.39B | +0.1% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
Compare NTRA, RDNT, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗